Current role
Alexander A. Fitzpatrick
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alexander A. Fitzpatrick
Earlier roles on record: General Counsel at Evofem Biosciences, Inc. (EVFM) until October 14, 2022. Evofem Biosciences, Inc. reported in an 8-K filed October 14, 2022 that Alexander A. Fitzpatrick resigned as General Counsel and Secretary, effective October 14, 2022. The proxy statement of ARS Pharmaceuticals, Inc. reports total compensation of $5,318,145 for Alexander A. Fitzpatrick in fiscal 2023, including a base salary of $515,000. Disclosed compensation is on record for 4 fiscal years.
“On October 10, 2022, Alexander A. Fitzpatrick, the General Counsel and Secretary of Evofem Biosciences, Inc. (the "Company") tendered his resignation to the Company, effective October 14, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
ARS Pharmaceuticals, Inc. (SPRY)
Proxy statement
CurrentStart not stated–present
-
Start not stated–2022-10-14
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ARS Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Donn Casale CEO, Board Member
- Rich Lowenthal CEO
- Richard Lowenthal CEO
- Pratik Shah Chairman
- Kathleen Scott CFO
- Russ Hawkinson CFO
- Brian Dorsey COO
- Brenton L. Saunders Board Member
- Jonathan S. Leff Board Member
- Laura Shawver Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Legal Officer and Secretary | $515,000 | $5,318,145 |
| 2022 | Evofem Biosciences, Inc. (EVFM) | General Counsel | $409,865 | $537,638 |
| 2021 | Evofem Biosciences, Inc. (EVFM) | General Counsel | $469,310 | $929,740 |
| 2020 | Evofem Biosciences, Inc. (EVFM) | General Counsel | $451,260 | $1,677,582 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.